top of page
NLA_SS_VEGAS_2024_design-01.jpg

2024 NLA Scientific Sessions Abstracts

Click on the posters to see an enlarged version, or scan the QR Codes with your phone to have a touch-free experience. 

Improving Risk Stratification in Severe Hypercholesterolemia: Provider recommendations for developing a program to communicate ASCVD risk

Presenting Author: Gemme Campbell-Salome, PhD
Authors:Zachary M. Salvati, Lauren Carr, Dylan Cawley, Amy R. Kontorovich, Vikas Pejaver, Tyler J. Schubert, Samuel S. Gidding, Matthew T. Oetjens, Laney K. Jones

Poster 134

NLA1a.png

Kiosk 1

Pericardial and pleural effusions after evolocumab in a patient with severe familial hypercholesterolemia

Presenting Author: Tia Bimal, MD
Authors: Pavlovic, Maia, BA, Eugenia, Gianos, MD, Anthony M. Szema, MD

1717092894218-c4de6467-f09c-4cb4-8ec7-b0317795f5dc_1.jpg

Poster 200

NLA2a.png

Kiosk 2

A patient who is nonresponsive to PSCK9 inhibition by both mAb and RNAi

Presenting Author: Tia Bimal, MD
Authors: Eugenia Gianos, MD, Courtney Davila, NP, Sean Donahoe, MD

2b.jpg

Poster 202

NLA2b.png

Kiosk 2

The Value of Lipid Testing in Recognizing Residual Risk

Presenting Author: Tia Bimal, MD
Authors: Ariadne Zias, BA, Julia K. Frangeskos, PA-C, Alana Gulliver, BA, Monique Carrero-Tagle, MS, Georgetta Vaidean, MD, PhD, Jessica M. Pena, MD, Sean Donohoe, MD, Eugenia Gianos, MD

2c.jpg

Poster 203

NLA2c.png

Kiosk 2

Real World Experience with Inclisiran in an Academic Medical Center

Presenting Author: Angelique Oakley, PharmD
Authors: Kelly Bartsch, Erica Davidson, Aaron Bagnola, Laxmi Mehta, John Larry, Wesley Milks

1716912813436-52dd29c9-5949-4245-947b-3077276c4433_1.jpg

Poster 137

NLA3a.png

Kiosk 2

Development and Validation of Clinical Criteria to Identify Familial Chylomicronemia Syndrome (FCS) in North America

Presenting Author: Robert Hegele, MD
Authors: Robert A Hegele, Zahid Ahmad, Ambika Ashraf, Andrew Baldassarra, Alan Brown, Alan Chait, Steven Freedman, Brenda Kohn, Michael Miller, Nivedita Patni, Daniel Soffer, Sarah N Gibbs, Irina Yermilov, Cynthia Campos, Eunice Chang, Michael S Broder

1716913183103-85eef25d-930b-41c2-a46d-0399b73dd1eb_1.jpg

Poster 117

NLA3a1.png

Kiosk 3

A Randomized, Placebo-Controlled Phase 3 Study of Olezarsen In Patients With Familial Chylomicronemia Syndrome: The Balance Trial

Presenting Author: Robert Hegele, MD
Authors: Erik S.G. Stroes, Veronica J. Alexander, Ewa Karwatowska-Prokopczuk, Marcello Arca, Christie M. Ballantyne, Handrean Soran, Thomas A. Prohaska, Shuting Xia, Henry N. Ginsberg, Joseph L. Witztum, Sotirios Tsimikas

Poster 125

NLA3b2.png

Kiosk 3

Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants

Presenting Author: Asia Sikora Kessler, PhD
Authors: T. Michelle Brown, Emily Bratlee-Whitaker, Marcello Arca, Alexis Baass, Seth J. Baum, Jean Bergeron, Daniel Gaudet, Ovidio Muñiz Grijalvo, Veronica J. Alexander, Montserrat Vera Llonch, Sheri Fehnel, Sam Tsimikas

1716913767642-098b1b97-b6bc-4bb7-92ca-de515fe65f3e_1.jpg

Poster 188

NLA3c.png

Kiosk 3

The Long-Term Efficacy and Safety of Evinacumab in Pediatric Patients with Homozygous Familial Hypercholesterolemia

Presenting Author: Albert Wiegman, MD
Authors: Susanne Greber-Platzer, Xue-Qiao Zhao, Shazia Ali, Alpana Waldron, M. Doortje Reijman, Eliot A. Brinton, Min-Ji Charng, Shubha Srinivasan, Carissa Baker-Smith, Seth Baum, Julie A. Brothers, Jacob Hartz, Patrick M. Moriarty, Poulabi Banerjee, Richard T. George, Boaz Hirshberg, Robert Pordy

1716914396925-1ceaf4dd-af48-4bb1-a86b-592f11f52757_1.jpg

Poster 186

NLA4a.png

Kiosk 4

ASCVD Risk Reduction in Patients with Immune-Mediated Inflammatory Disease: A Retrospective Quality Assessment Study

Presenting Author: Deepak Vedamurthy, MD
Authors: Deepak Vedamurthy MD, Srinivas Denduluri PhD, Emma MacAllister CRNP, Archna Bajaj MD, Daniel Soffer MD, Douglas Jacoby MD

1716914681826-7d7c32ad-b527-471a-aa55-d62e614ed440_1.jpg

Poster 207

NLA4b.png

Kiosk 4

Achievement of Low-Density Lipoprotein Cholesterol (LDL-C) Thresholds in Patients with Very High-Risk Atherosclerotic Cardiovascular Disease (ASCVD)

Presenting Author: Elisa Worledge, PharmD
Authors: Sarah J. Billups, Joseph J. Saseen

Poster 130

NLA5a.png

Kiosk 5

Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer

Presenting Author: Dhaval Naik, DO
Authors: Eldon Matthia MD, Dhaval Naik DO

1716915505728-a7c0ed17-796c-41da-afd7-d046be9bc329_1.jpg

Poster 157

NLA5b.png

Kiosk 5

Obicetrapib alone and with ezetimibe reduces non-HDL-C by enhanced LDL-receptor-mediated VLDL clearance and increased net fecal sterol excretion

Presenting Author: José Inia, PhD
Authors: José A. Inia, Nanda Keijzer, Nicole Worms, Anita van Nieuwkoop, Marc Ditmarsch, J. Wouter Jukema, Albert K. Groen6, John Kastelein, Anita M. van den Hoek, Geurt Stokman, Elsbet J. Pieterman, Hans M.G. Princen

1716915907552-b83fa03b-40e5-4f4d-a886-a0e3158c6933_1.jpg

Poster 141

NLA6a.png

Kiosk 6

Interaction of AI-Enabled Quantitative Coronary Plaque Analysis Volumes on Coronary CT Angiography, FFRCT, and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry

Presenting Author: Jonathon Leipsic, MD
Authors: Dundas J., Fairbairn T., Ng N., Sussman V., Guez I., Rosenblatt R., Koweek L., Douglas P., Rabbat M., Pontone G., Chinnaiyan M K., De Bruyne B., Bax J J., Amano T., Nieman K., Rogers C., Kitabata H., Sand N.P.R., Kawasaki T., Mullen S., Huey W., Matsuo H., Patel M.R., Norgaard B.L., Ahmadi A., Tzimas G., on behalf of The ADVANCE investigators

1716916284900-032231df-6020-405e-b338-31977687d035_1.jpg

Poster 177

NLA6b.png

Kiosk 6

Real-World Experience with Inclisiran at a Large Academic Lipid Clinic

Presenting Author: Donya Mazdeyasnan, BS
Authors: Tommy T. Chiou MD, Pam R. Taub MD, Michael J. Wilkinson MD

1716924904714-bbf27cbf-e50b-4a66-8246-da44990c1d99_1.jpg

Poster 174

NLA7a.png

Kiosk 7

Unmasking the Silent Culprit: Lipoprotein(a) Elevation in a Previously Healthy Individual

Presenting Author: Kathryn Manalo, DO
Authors: Alexis Arrigo DO, Xiarapeti Tieliwaerdi MD, Edmund Appiah-Kubi MD, Sana Khan MD, Andrew Oehler MD

1716925220694-1e32d44e-8498-457d-8c15-fa9a15de0bab_1.jpg

Poster 187

NLA7b.png

Kiosk 7

Calculated Small Dense LDL-C has a stronger association to atherosclerotic cardiovascular events than other components of the lipid panel.

Presenting Author: Rafael Zubiran, MD
Authors: Maureen Sampson, Alan T. Remaley

1716925867078-e143bc80-b131-4ed4-be12-e47e32774396_1.jpg

Poster 156

NLA8a.png

Kiosk 8

Process Mapping the Lipid Management Patient Pathway in Six Health Systems for Identification of Barriers to Guideline-Directed Care

Presenting Author: Liz Olson, BA
Authors: Liz Olson, Katerine Overton, Rebecca Alicki, Allie Bateman, Eddie Pan, Michelle Congdon, Chiadi Ndumele MD

1716926143830-01b2d56b-73d9-4b12-9501-c66fbbe5ea32_1.jpg

Poster 142

NLA8b.png

Kiosk 8

Impact of Grant-Funded Coronary Artery Calcium Score on Cardiovascular Risk Assessment and Management in an Underserved Population

Presenting Author: Matthew Sangoi, MD
Authors: Maxwell Ambrosino, Nasser Monzer, Deepak Vedamurthy, Robert Norris, Daniel Soffer, Douglas Jacoby

1716926775768-2c1d697f-876f-4407-ab57-2f586693b23b_1.jpg

Poster 136

NLA9a.png

Kiosk 9

Accelerated Atherosclerosis In A Patient With Multifactorial Chylomicronemia Syndrome (MCS), Elevated Lp(a), APOE2/4 Genotype and Diabetes Mellitus.

Presenting Author: Loba Alam, MD
Authors: Loba Alam MD, Mendel Roth PhD, Tiffany Haynes MD, Robert Fishberg MD FACC.

Screenshot 2024-06-01 at 1.24.54 PM.png

Poster 159

NLA9update.png

Kiosk 9

Racial Inequities in Coronary Artery Calcium Screening and Follow-up

Presenting Author: Afolasayo Aromiwura, MD
Authors: Muhammad Umer MD, Ibtihaj Fughhi MD, Thomas Beyerle MD, Zachary Hagemeyer MD, Hardeep Dholiya MD, Shivam Gulati MD, Wilfred Furtado MD, Dinesh Kalra MD

Poster 201

NLA10a.png

Kiosk 10

Differences in clinical outcomes between non-obese Caucasian and Hispanic populations who have hyperlipidemia

Presenting Author: Sindhu Kishore, MD
Authors: Sindhu Kishore, M.D., Gehna Kishore, M.D., Mehnaaz Ali, MPH, Sam Miller, M.D., Kamal Shemisa, M.D.

1716954403294-f1f12055-b1d1-4ea0-b931-6632be287853_1.jpg

Poster 223

NLA11a1.png

Kiosk 11

Protein Calorie Malnutrition Effect on Clinical Outcomes And Resource Utilization in Patients Admitted With Acute Pancreatitis And Dyslipidemia

Presenting Author: Vassel Bitar, MD
Authors: Hijazi, Mohamad, MD, Albuni, Mhd Kutaiba, MD, Bitar, Bassel, MD, Eshghabadi, Amin, MD, Khan, Fayaz, MD, Ajenaghughrure, Godbless, MD, Shemisa, Kamal, MD

1716927750235-ff93c563-d44d-438c-aa70-0e699fbdbd11_1.jpg

Poster 216

NLA10b.png

Kiosk 10

Differences in clinical outcomes between non-obese Caucasian and Asian populations who have hyperlipidemia

Presenting Author: Sindhu Kishore, MD
Authors: Sindhu Kishore, M.D., Gehna Kishore, M.D., Mehnaaz Ali, MPH, Sam Miller, M.D., Kamal Shemisa, M.D.

1716954725776-abab3f11-0215-48a4-ab14-a8ff03f13087_1.jpg

Poster 227

NLA11c.png

Kiosk 11

Differences in clinical outcomes between non-obese African American and Asian populations who have hyperlipidemia

Presenting Author: Sindhu Kishore, MD
Authors: Sindhu Kishore, M.D., Leonid Khokhlov, M.D., Gehna Kishore, M.D., Godbless Ajenaghughrure, M.D., Kamal Shemisa, M.D.

1716955010136-f68de77a-0811-408f-9b04-e560f4da0882_1.jpg

Poster 231

NLA11d.png

Kiosk 11

Differences in clinical outcomes between non-obese Hispanic and Asian populations who have hyperlipidemia

Presenting Author: Sindhu Kishore, MD
Authors: Sindhu Kishore, M.D., Leonid Khokhlov, M.D., Gehna Kishore, M.D., Godbless Ajenaghughrure, M.D., Kamal Shemisa, M.D.

1716955449062-49b563f1-a597-48a2-8003-e4e4e767ac67_1.jpg

Poster 232

NLA11e.png

Kiosk 11

Assessment of unmet clinical needs and healthcare resource use among statin-treated patients with or at risk of developing ASCVD

Presenting Author: Andrew Hsieh, PharmD
Authors: Andrew Hsieh, Bob Rambo, Brian Leinwand, Ahan Ali, Dushyant Katariya, Robert Shepherd, Nancy Ortiz

1716956626493-cc706f58-0d85-474d-9425-45135e0f82e1_1.jpg

Poster 139

NLA12c.png

Kiosk 12

Detailed Family History of Premature Atherosclerotic Cardiovascular Disease to Guide Lipoprotein(a) Testing: The Multi-Ethnic Study of Atherosclerosis

Presenting Author: Alexander Razavi, MD
Authors: Alexander C. Razavi, Harpreet S. Bhatia, Zeina A. Dardari, Anurag Mehta, Khurram Nasir, Ron Blankstein, Ijeoma Isiadinso, Arshed A. Quyyumi, Viola Vaccarino, Jonathan A. Fialkow, Matthew J. Budoff, Roger S. Blumenthal, Seamus P. Whelton, Martin Bødtker Mortensen, Laurence S. Sperling, Kunihiro Matsushita, Michael J. Blaha, Omar Dzaye

1716956989360-e9fcd10b-4235-48fa-8ce4-9bdec4cbe56c_1.jpg

Poster 121

NLA12d.png

Kiosk 12

ASCVD risk stratification in a large urban clinic – role of CACS in reclassifying Black versus White individuals seen for preventive care.

Presenting Author: Muhammad Umer, MD
Authors: Sindhu Kishore, M.D., Leonid Khokhlov, M.D., Gehna Kishore, M.D., Godbless Ajenaghughrure, M.D., Kamal Shemisa, M.D.

1716957330520-f3a266be-2698-49ca-b499-cc793b49f6e5_1.jpg

Poster 199

NLA12e.png

Kiosk 12

A Rare Encounter: Familial Lipoprotein Lipase Deficiency in Pregnancy - Case Review and Emerging Therapies for Familial Chylomicronemia Syndrome

Presenting Author: Yasmin Bains, DO
Authors: Aman Rajpal

1716957834841-3748803e-8069-4ed4-8d7d-ee9f9cdc9585_1.jpg

Poster 123

NLA13a.png

Kiosk 13

Pharmacological trials for the treatment or prevention of coronary artery disease: Analysis of ClinicalTrials.gov listings from 2008 to 2022

Presenting Author: Gerald Chi, MD
Authors: Gerald Chi, M. Cecilia Bahit, Serge Korjian, Laith Allaham, Alka Shaunik, C. Michael Gibson

1716995227256-4dbad804-c4ee-4c53-a7b4-6abe0dc4771c24-Abstract 111-CAD CVOT-Paul Nara_1.jpg

Poster 111

NLA13b.png

Kiosk 13

Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Robust and Durable TG Reductions in Patients With Mixed Dyslipidemia, MUIR Final Results

Presenting Author: Christie Ballantyne, MD
Authors: Vasas S, Azizad M, Clifton P, Rosenson RS, Hellawell J, Chang T, Melquist S, Fu R, Mushin M, San Martin J, and Gaudet D

Poster 124

NLA13c.png

Kiosk 13

Multidisciplinary Management of Lipoprotein X-Induced Hyperlipidemia Secondary To Drug-Induced Liver Injury

Presenting Author: Amrita Krishnamurthy, MD
Authors: Samuel M. Kim

1716996240812-e272e1cb-e5f6-46b7-bdba-a9f0c4a3d198_1.jpg

Poster 132

NLA13d.png

Kiosk 13

Real-world experience of inclisiran at the University of Pennsylvania Health Systems

Presenting Author: Nicole Wei, BS
Authors: Marjorie Risman, Robert F. Tobin III, Archna Bajaj

1716996508711-00fd84ae-e62d-41a2-9f10-a3660fc59025_1.jpg

Poster 166

NLA13e.png

Kiosk 13

A Father’s Last Message: The Value of Polygenic Risk Scoring in Familial CAD

Presenting Author: Ranvir Bhatia, BA
Authors: Daniel E. Soffer

1716996797157-25a673d2-2399-4199-85e0-93daadc3b44e_1.jpg

Poster 160

NLA14a.png

Kiosk 14

Trends of global disease burden attributable to diet low in polyunsaturated fatty acids from 1990 to 2019: a global burden of disease study analysis

Presenting Author: Heyue Du, MD
Authors: Ahmed Abu-Haniyeh

1716997072471-b60d09e9-3ac0-43a9-9f38-f002302488e4_1.jpg

Poster 169

NLA14b.png

Kiosk 14

Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Deep and Durable TG Reductions in Patients With SHTG, SHASTA-2 Final Results

Presenting Author: Daniel Gaudet, MD
Authors: Gaudet D, Pall D, Watts GF, Nicholls SJ, Rosenson RS, Modesto K, Chang T, Melquist S, Fu R, Muhsin M, San Martin J

Poster 131

NLA14c.png

Kiosk 14

Rates of lipid testing among patients with atherosclerotic cardiovascular disease within a large community-based health system

Presenting Author: Andrew Nute, MPH
Authors: Hsin-Fang Li, Roshanthi Weerasinghe, Staci Wendt, Eduard Sidelnikov, Bethany Kalich, Niranjan Kathe, Ty J. Gluckman

1717004425145-2fc0b112-f708-40c9-b3ac-fc563e284d59_1.jpg

Poster 171

NLA14d.png

Kiosk 14

Rethinking Prevention: Need for earlier intervention in Familial Hypercholesteremia despite Statin and PCSK9 Inhibitor Therapy

Presenting Author: Nosagie Ohonba, MBBS
Authors: Tiffany Haynes, Matthew Proute, Robert Fishberg

1717005076247-28ba6a9b-9328-4ced-8e38-665e1816eb8d_1.jpg

Poster 210

NLA14e.png

Kiosk 14

FADS2 Indel polymorphism rs66698963 predicts colorectal polyp prevention by the n-3 fatty acid EPA

Presenting Author: Ge Sun, PhD
Authors: Ge Sun, Yan Ning, John R Davies, Robert C Block, Kumar D Kothapalli,, J Thomas Brenna, Mark A Hull

1717005523731-46bda65a-8487-4590-badf-07fe27703323_1.jpg

Poster 122

NLA15a.png

Kiosk 15

Attitudes and Barriers to Lipoprotein(a) Testing: A survey of providers at the University of Pennsylvania Health System

Presenting Author: Jillian D’souza, BS
Authors: Archna Bajaj, MD, MSCE

1717005735841-770479f8-366c-4041-89cf-ee8ed2feb104_1.jpg

Poster 126

NLA15b.png

Kiosk 15

OBICETRAPIB TREATMENT INCREASES PRE-BETA1 HDL AND LIPOPHILIC ANTIOXIDANTS IN THE OCEAN AND ROSE2 STUDIES

Presenting Author: Eric Niesor, PhD
Authors: Eric Niesor, Marc Ditmarsch, Serge Rezzi, Stéphane Canarelli, Andrew Hodgson, Pablo Hanggi, John J.P. Kastelein

1717006189992-743ae921-534a-4ed5-9a8b-25f079a5dde2_1.jpg

Poster 140

NLA15c (1).png

Kiosk 15

Descriptive Analysis of Patients at the Georgia Heart Institute Center for Cardiovascular Prevention, Metabolism, and Lipids

Presenting Author: Anna Biggins, RD
Authors: Jaime Burkle

1717102713641-c11e3a54-2f02-4782-b41a-056d540459e6_1.jpg

Poster 155

NLA15d.png

Kiosk 15

Evaluation of chenodeoxycholic acid treatment in adult patients with cerebrotendinous xanthomatosis: A randomized, placebo-controlled Phase 3 study

Presenting Author: P. Barton Duell, MD
Authors: Andrea E. DeBarber, Yaz Y. Kisanuki, Paulo R. Nobrega, Ryan Himes, Suman Jayadev, John A. Bernat, Vikram Prakash, James B. Gibson, Austin Larson, Paulo Sgobbi, Edward Murphy, Brian Fedor, Cheryl Wong Po Foo, Rana Dutta, Michael Imperiale, Will Garner, Pamela Vig, Sarah Perez, Ritesh A. Ramdhani, Jonas Alex Saute

Poster 168

NLA15E2.png

Kiosk 15

Familial Hypercholesterolemia Diagnosis and Management: Insights from the NIH Precision Medicine Initiative All of Us Study

Presenting Author: Spoorthy Vangala, MBBS
Authors: Spoorthy Vangala, Michael Christof , Trinh Do, Nathan D Wong, Robert Block

1717009599745-ad798713-cb16-451b-b4c0-395fe073ab8824_1.jpg

Poster 163

NLA16a.png

Kiosk 16

The Outcome of Coronary Artery Bypass Graft in Patient with Prediabetes.

Presenting Author: Joseph Amoah, MD
Authors: Brittany Smith, Michael Fatuyi, Francisco Somaza Cano

1717010180027-68ff2f94-54b5-4020-ac9e-a2262c5d19cd_1.jpg

Poster 224

NLA16b.png

Kiosk 16

The Family Heart Foundation™ Flag, Identify, Network, Deliver—Familial Hypercholesterolemia (FIND-FH™) Program and Collaborative Learning Network (CL

Presenting Author: George Blike, MD
Authors: George Blike MD, Lori Key RN MBA, Funke Oladele MBA, Mary McGowan MD, Diane MacDougall MA, Amit Khera MD, Scott Merryman MD, Danny Eapen MD, Kerrilynn Hennessey MD, Deepak Vedamurthy MD, Allison Hawke BA, Katherine Wilemon BS

1717010457713-1da4f34b-b51c-45e7-a02e-f99d9780632a_1.jpg

Poster 226

NLA16c.png

Kiosk 16

Fellow Quality Improvement Project:  Identification of high risk CAD patients and referral to newly established lipid clinic, what are the clinical implications?

Presenting Author: Jia-Hong Chen, MD
Authors: Shubash Adhikari, Mohammed J. Arisha, Said Hajouli, Frank H. Annie, Cassidy Crews, Sarah Rinehart

1717010890854-665baa1e-329c-4d64-8844-352e21f19cb4_1.jpg

Poster 214

NLA16d.png

Kiosk 16

Fenofibric Acid has Distinct Molecular Location in Reconstituted Liver Membranes and Higher Affinity Compared to Pemafibrate

Presenting Author: R. Mason, PhD
Authors: Samuel C.R. Sherratt

1717011204873-1b383bba-a8eb-4507-a4e4-1572b5cb27c4_1.jpg

Poster 170

NLA16e.png

Kiosk 16

Genetic Testing Results in a Preventative Cardiology and Inherited Lipid Disorders Clinic

Presenting Author: Bella Brosious, BS
Authors: Isaac Elysee, Archna Bajaj

1717011949148-109fac10-797f-4d1e-9366-c89ba50d6b812024_1.jpg

Poster 167

NLA17a.png

Kiosk 17

Familial Hypercholesterolemia: Can Continuing Medical Education Help Address Barriers to Screening in Children?

Presenting Author: Kristin Della Volpe, BA
Authors: Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA, Seth S. Martin, MD, MHS, FAHA, FACC, FASPC, Carole Drexel, PhD

1717012212933-cd72582a-5ec9-41ba-9de6-e742d9651579_1.jpg

Poster 135

NLA17b.png

Kiosk 17

Cardiovascular trials over the last 15 years: Analysis of the characteristics and trends of ClinicalTrials.gov listings from 2008 to 2022

Presenting Author: Gerald Chi, MD
Authors: Gerald Chi, Laith Allaham, Alberto Castro Molina, M. Cecilia Bahit, Serge Korjian, Clara Vitarello, Alka Shaunik, C. Michael Gibson

1717012532543-1ab3374e-2049-49f6-9840-92a6bd2be92424-Abstract 112-CVOT trends-Paul Nara_1.

Poster 112

NLA17c.png

Kiosk 17

A Case of Familial Hypoalphalipoproteinemia with Significant Premature Atherosclerosis

Presenting Author: Jordan Price, MD
Authors: Sumer Moussa, MD , On Chen, MD, Tahmid Rahman, MD

1717012743955-61cc58ae-3118-450f-b517-25fc190b0db4_1.jpg

Poster 182

NLA17d.png

Kiosk 17

Patients Admitted With Acute pancreatitis and Dyslipidemia Affected by Non-Alcoholic Fatty Liver Disease Are Associated With Worse Clinical Outcomes

Presenting Author: M Kenan Rahima, MD
Authors: Bitar, Bassel, MD, Hijazi, Mohamad, MD, Albuni, Mhd Kutaiba, MD,, Eshghabadi, Amin, MD, Khan, Fayaz, MD, Ajenaghughrure, Godbless, MD, Shemisa, Kamal, MD

1717013403096-482c31b4-4676-445d-9609-c9106117b187_1.jpg

Poster 213

NLA18a.png

Kiosk 18

A novel nanoparticle lipoprotein free cholesterol mass transfer assay.

Presenting Author: Rafael Zubiran, MD
Authors: Edward B. Neufeld, Alan T. Remaley

1717013048828-f37e2fcb-1784-4c9d-b912-2fa60fed6283_1.jpg

Poster 179

NLA17e.png

Kiosk 17

Clinical Outcomes And Mortality in Heart Failure And Chronic Kidney Disease Patients Admitted With Non-Variceal Upper Gastrointestinal Bleeding

Presenting Author: M Kenan Rahima, MD
Authors: Bitar, Bassel, MD, Hijazi, Mohamad, MD, Albuni, Mhd Kutaiba, MD,, Eshghabadi, Amin, MD, Khan, Fayaz, MD, Ajenaghughrure, Godbless, MD, Shemisa, Kamal, MD

1717013666170-2f587b10-1855-46c7-b78b-54e05cedb1f1_1.jpg

Poster 165

NLA17b (1).png

Kiosk 18

Obicetrapib does not Accumulate in Adipose Tissue: Results from Studies in Man and Non-human Primates

Presenting Author: John Kastelein, MD
Authors: John JP Kastelein, Marc Ditmarsch, Douglas Kling, Danielle Curcio, Erin Wuerdeman, Mary Dicklin, Michael Davidson

Poster 127

NLA18c.png

Kiosk 18

Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome

Presenting Author: Simon-Pierre Guay, MD
Authors: Simon-Pierre Guay, Martine Paquette, Amélie Taschereau, Véronique Desgagné, Luigi Bouchard, Sophie Bernard, Alexis Baass

1717014717750-e13b6138-8da9-4d99-8d71-2f05b9b40866_1.jpg

Poster 133

NLA18d.png

Kiosk 18

Racial Variations in SGLT2 Inhibitor Prescriptions

Presenting Author: Rahul Rege, MD
Authors: Christian Leung, Spencer Weintraub, Benjamin Hirsh

1717015297586-5643c73b-0399-4062-98bd-a81b9f1d219e_1.jpg

Poster 229

NLA18e.png

Kiosk 18

Association Between Niacin-ER Use, Safety, and Cardiovascular Events. A Single Center Experience.

Presenting Author: Halima Tabani, BSN
Authors: Halima Tabani RN, BSN, Chris A. Caraang MD, FACC

Poster 234

NLA19a.png

Kiosk 19

High rates of cardiovascular events in patients with multivessel disease in the first year post-myocardial infarction: A systematic literature review

Presenting Author: M. Cecilia Bahit, MD
Authors: M. Cecilia Bahit, Serge Korjian, Yazan Daaboul, Gerald Chi, Ginger Jiang, Peter Libby, Deepak L. Bhatt, Matthew Reynolds, Roxana Mehran, Paul M. Ridker, Suzanne Baron, Frank M. Sacks, Paul Nara, C. Michael Gibson

1717075561751-0999735d-3375-4692-8ab8-769bab65939d24-Abstract 113-MVD SLR-Alka Shaunik_1.j

Poster 113

NLA19b.png

Kiosk 19

Age- and Sex-Specific Nomographic CT Quantitative Plaque Data From a Large International Cohort

Presenting Author: Jonathon Leipsic, MD
Authors: Russell Everett, Gaurav Gulsin, Mariama Akodad, David Meier, Kavishka Sewnarain, Zain Ally, Rawan Alnamasy, Nicholas Ng, Stephanie Sellers, Philipp Blanke, Sarah Mullen, Georgios Tzimas

1717075760059-024f6d2c-ee01-4df1-8a9a-c95eadaea98a_1.jpg

Poster 172

NLA19c.png

Kiosk 19

Centralized Cascade Screening for Familial Hypercholesterolemia: Perspectives of Patients and Providers

Presenting Author: Megan Roberts, PhD
Authors: Megan C Roberts, Ashley R Brown, Marina Cuchel, Laney K Jones, Mary P McGowan, Kyaw Soe, William S Weintraub

1717075963239-a7f6f317-080c-4e73-88b1-fbe4a8e044e0_1.jpg

Poster 215

NLA19d.png

Kiosk 19

Comparison of package insert vs.real world safety data from branded icosapent ethyl users: a select analysis utilizing MarketScan data

Presenting Author: Richard Hansen, PhD
Authors: Handrean Soran, Om P. Ganda, Richard A. Hansen, Nilima Justice, Sephy Philip

1717076208207-ce2bc21e-68dc-4941-826e-a4277b25b6cc_1.jpg

Poster 192

NLA19e.png

Kiosk 19

The Lomitapide Observational Worldwide Evaluation Registry (LOWER) - Nine-year effectiveness and safety data in HoFH

Presenting Author: Dirk Blom, MD
Authors: Dirk Blom, Christopher P Cannon, Dominique Larrey, Lukas Makris, Sallyann O’Brien

1717076452332-a9641eb6-1dd2-453b-9677-9dac87ab4f50_1.jpg

Poster 145

NLA20a.png

Kiosk 20

Oleocanthal-rich olive oil’s effect on postprandial platelet activity and oxidative stress markers of type 2 diabetic patients

Presenting Author: Maria Efthymia Katsa, MS
Authors: Andrea Paola Rojas Gil, Paraskevi Detopoulou, Evangelia-Mantelena Makri, Spyridon Papadogiannis, Anastasios Ioannidis, Eleni Melliou, Prokopios Magiatis,Tzortzis Nomikos

Poster 206

NLA20b.png

Kiosk 20

Clinical Outcomes in Patients admitted with Diabetes Mellitus and Chronic Kidney Disease Affected by Non-Alcoholic Fatty Liver Disease

Presenting Author: M Kenan Rahima, MD
Authors: Bitar, Bassel, MD, Hijazi, Mohamad, MD, Albuni, Mhd Kutaiba, MD,, Eshghabadi, Amin, MD, Khan, Fayaz, MD, Ajenaghughrure, Godbless, MD, Shemisa, Kamal, MD

1717076908543-9045bc03-dda4-45e6-ba72-d23dbd6bd038_1.jpg

Poster 193

NLA20c.png

Kiosk 20

A controlled intervention restricting AGEs improves carboxymethyl lysine, RAGE, lipid, and inflammatory indices in patients undergoing hemodialysis

Presenting Author: Paraskevi Detopoulou, PhD
Authors: Adamantia Aroni, Dimitrios Presvelos, Eirini Kostopoulou, Anastasios Ioannidis, Georgios Panoutsopoulos, Sofia Zyga, Georgios Kosmidis, Bessie E. Spiliotis, Andrea Paola Rojas Gil

1717077084004-e9f086d7-a38a-4fe4-a2dc-6a6e7d43c6de_1.jpg

Poster 185

NLA20d.png

Kiosk 20

Elevated Serum Small Dense Low Density Lipoprotein Cholesterol and Lipoprotein(a) Levels in Preeclampsia

Presenting Author: Robert Wild, MD
Authors: N Paneth, G Abela, M Fernandes, D Zhao, KR Hansen, A Ott, E Wolfe, EJ Schaefer

1717077281291-244b5b17-3dc3-4b28-b58e-03d9a384b9a326AO3 (Final1)NPESrwR_1.jpg

Poster 106

NLA20e.png

Kiosk 20

Lomitapide in pediatric patients with homozygous familial hypercholesterolemia – Analysis of secondary and safety endpoints from the APH-19 study

Presenting Author: Luis Masana, MD
Authors: Luis Masana, Alberto Zambon, Claus Peter Schmitt, Christina Taylan, Joenna Driemeyer, Hofit Cohen, Paola Sabrina Buonuomo, Abdullah Alashwal, Mohammed Al-Dubayee, José Luis Diaz-Diaz, Faouzi Maatouk, Sergio Martinez-Hervas, Brian Mangal, Naji Kholaif, Sandra Löwe

1717077620776-36f6eea0-4939-48bb-88f3-db30557005ea_1.jpg

Poster 147

NLA21a.png

Kiosk 21

The Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE) Study – Phase 1 Results

Presenting Author: Matthew Cooper, MD

Authors: Matthew Cooper, Iulia Iatan, Thomas M. Roston, Nicol Vaizman, Lubomira Cermakova, Kyle Hui, G.B. John Mancini, Christopher B. Fordyce, Liam R. Brunham

1717077933817-7c7d435d-020d-443c-abcb-622df4513993_1.jpg

Poster 161

NLA21b.png

Kiosk 21

Patients perceive a considerable treatment burden in the first year after a myocardial infarction: Results from an online US patient survey

Presenting Author: M. Cecilia Bahit, MD
Authors: M. Cecilia Bahit, Serge Korjian, Gerald Chi, Yazan Daaboul, Ginger Jiang, Deepak L. Bhatt, Roxana Mehran, Paul Nara, C. Michael GibsonD

1717078203096-c595d339-a7bd-4d4a-b25f-c082cbe8104924-Abstract 114-Pt Perspectives Treatmen

Poster 114

NLA21c.png

Kiosk 21

Discrepancies in Prescribing Practices for SGLT2 Inhibitors Between Sexes

Presenting Author: Rahul Rege, MD
Authors: Christian Leung, Spencer Weintraub, Benjamin Hirsh

1717078398617-45667124-8373-4b6a-b285-5c25ea9665a2_1.jpg

Poster 230

NLA21d.png

Kiosk 21

Comparative Assessment of hsCRP and Apolipoprotein B as ASCVD Risk Biomarkers

Presenting Author: Saheed Amusat
 

1717078685850-85b99c58-9a11-4468-a7fd-5f32655d2922_1.jpg

Poster 115

NLA21e.png

Kiosk 21

Tailored Therapeutic Strategies for the Management of Chylomicronemia Syndrome

Presenting Author: Sylvia Chlebek, DO
Authors: Annie Skariah MD, Garnet Meier MD, Nataliya Pyslar MD

1717078991918-8add7d8e-18a5-4465-a4ee-f533d041965e_1.jpg

Poster 181

NLA22a.png

Kiosk 22

Negative LDL-C levels with Detectable Apolipoprotein B: Surrogate Markers of Atherosclerotic Disease and Cardiac Event Risk

Presenting Author: Matthew Proute, MBBS
Authors: Matthew Proute, MBBS, Tiffany Haynes, MD, Nosagie Ohonba, MBBS, Robert Fishberg, MD, FACC

Poster 208

NLA22b.png

Kiosk 22

SYNERGISTIC EFFECT OF OBICETRAPIB AND EZETIMIBE ON CIRCULATING LDL PARTICLES

Presenting Author: Michael Davidson, MD
Authors: Michael H. Davidson, Christie M. Ballantyne, Andrew Hsieh, Marc Ditmarsch, Douglas Kling, Danielle Curcio, Mary R. Dicklin, John J.P. Kastelein

1717080944060-33173308-0776-451a-889c-b78ed567b2d1_1.jpg

Poster 138

NLA22c.png

Kiosk 22

Effect of diabetes mellitus (T2DM) medications on lipid parameters in veterans with T2DM and metabolic dysfunction associated steatotic liver disease (MASLD)

Presenting Author: Sabyasachi Sen, MD
Authors: Jessica Khoury, Shannen Ubalde, Sabyasachi Sen

1717081255829-35d9a9b8-761f-4e6c-a561-17f253c384d02024-v2_1.jpg

Poster 176

NLA22d.png

Kiosk 22

Unique case of Familial Hypobetalipoproteinemia (FHBL)

Presenting Author: Sohil Golwala, MD
Authors: Daniel Soffer M.D.

1717081539191-6646aeda-d009-4669-9ceb-78e370c54334_1.jpg

Poster 211

NLA22e.png

Kiosk 22

Health Outcomes and Survival of Patients With Severe Hypertriglyceridemia After Acute Pancreatitis

Presenting Author: Michael Broder, MD
Authors: Michael S. Broder, Eunice Chang, Jonathan L. Respress, Kathleen F. Villa, Nathan D. Wong

1717083740602-fe025de7-d353-4a76-b573-89948ba0eaa4_1.jpg

Poster 118

NLA23b.png

Kiosk 23

Food Compass Score is inversely related to inflammatory markers and cardiovascular disease incidence: results from the ATTICA cohort study (2002-2022)

Presenting Author: Paraskevi Detopoulou, PhD
Authors: E Damigoua, S Antonopoulou, C Chrysohoou, F Barkas, E Vlachopoulou, G Anastasiou, C Tsioufis, E Liberopoulos, P Sfikakis, C Pitsavos, D Panagiotakos

Poster 180

NLA23c.png

Kiosk 23

A Case of Familial Hypoalphalipoproteinemia with Significant Premature Atherosclerosis

Presenting Author: Tahmid Rahman, MD
Authors: Sumer Moussa, MD , On Chen, MD, Tahmid Rahman, MD

1717012743955-61cc58ae-3118-450f-b517-25fc190b0db4_1.jpg

Poster 182

NLA17d.png

Kiosk 23

Cardiovascular Outcomes Unveiled: Bempedoic Acid in Hyperlipidemia—A Comprehensive Updated Systematic Review and Meta-analysis of RCTs

Presenting Author: Lanson Colaco, MBBS
Authors: Colaco, L.B., Ali S., Asghar MS., Brands CK., Shimshak TMMichelle Congdon, MBA

Poster 219

NLA24a.png

Kiosk 24

Xanthelasma Associated with Defective Reverse Cholesterol Transport, Resolution with Rosuvastatin/Ezetimibe: A Case Report

Presenting Author: Michael Doyle, MD
 

1717084774033-30e8ab44-14fb-4902-881d-0a3ed0710c92_1.jpg

Poster 194

NLA24b.png

Kiosk 24

Elevated levels of Lp(a) are associated with circulating levels of PCSK9 and coronary atherosclerosis as detected by cardiac computed tomography angiography

Presenting Author: Szilard Voros, MD
Authors: Bradley Brown, David Watson, Wess Boatwright, Thomas Dayspring, Michael Barnes

1717085358212-7f3221bd-23fc-4a1e-9e2c-288ea47159a0_1.jpg

Poster 150

NLA24e.png

Kiosk 24

Lipoprotein (a) Discovery Project: Initiative to Identify Awareness and Models of Lipoprotein (a) Testing for National Education

Presenting Author: Kristin Colson, MS
Authors: David Peña, MHA; Liz Olson, PMP; Michelle Congdon, MBA

1717085606066-8f8f699a-693f-49f1-96c8-91146b2a23ab_1.jpg

Poster 154

NLA25a.png

Kiosk 25

Clinical outcomes in patients admitted with acute coronary syndrome affected by protein calorie malnutrition.

Presenting Author: Mohammad Amin Eshghabadi, MD
Authors: Gregory Pierce, Kenan Rahima, Sila Faxas, Borna Mansouri, Maneet Multani, Joe Alfeghaly, Angel Mena

1717085823816-616ba23d-f60d-4e0b-a3c1-4e46404d37fa_1.jpg

Poster 173

NLA25b.png

Kiosk 25

Lipid lowering Injectable Clinic- novel idea for improving compliance with twice yearly dosing of Inclisiran

Presenting Author: Sarah Ali-Qureshi, MD
Authors: A. Ali MSc, F.Popescu MBA, M.Shaat MSc.

1717086094940-2135c7be-9264-4d9b-8f51-117c1c18ee44_1.jpg

Poster 204

NLA25d.png

Kiosk 25

lipoprotein(a), electronic health record, atherosclerotic cardiovascular disease, atherogenic lipoprotein

Presenting Author: Bhavana Upadhyaya, BA
Authors: Bhavana Upadhyaya, Kun Yang, Caroline Mackey, Xin Tu

1717087167476-53542d58-585d-4b41-a524-e11bc25fe6f6_1.jpg

Poster 154

NLA26a.png

Kiosk 26

Real-World Evaluation of Lipid Testing Rate and Treatment Target Attainment Among High-Risk Patients: Post Release of the 2018 AHA/ACC Practice Guidelines

Presenting Author: Nilesh Gangan, PhD
Authors: Jay Visaria, Eric Stanek, Jeff White, Mark J. Cziraky

1717087353919-12ff1d99-8e77-4ed7-98f0-95c95a870fc2_1.jpg

Poster 198

NLA26b.png

Kiosk 26

Familial Hypercholesterolemia Cascade: On the Road to Universal Screening

Presenting Author: Tiffany Haynes, MD
Authors: Tiffany Haynes MD, Matthew Proute MBBS, Nosagie Ohonba MBBS, Jeffery Feldman MD, FACP, Robert Fishberg MD, FACC

1717087514147-f7d51842-04a4-4fba-b711-d80b7435a443_1.jpg

Poster 197

NLA26d.png

Kiosk 26

THE EXCEPTION THAT PROVES THE RULE: ACUTE MYOCARDIAL INFARCTION IN A PERSON ATEXTREMELY LOW RISK FOR PLAQUE RUPTURE

Presenting Author: Tiffany Haynes, MD
Authors: Matthew Proute MBBS, Nosagie Ohonba MBBS, Robert Fishberg MD, FACC

1717087692697-7c9b7d4d-78ce-4dec-a942-1f755cf94bde_1.jpg

Poster 175

NLA26e.png

Kiosk 26

A Pilot Study of Triglyceride Screening in Blood Donors

Presenting Author: Caroline Abe, MD
Authors: Emily Decicco MD, Stephen Eason MBA, Frances Compton MD, Merlyn Sayers MBBCh PhD, Amit Khera MD, Zahid Ahmad MD

Poster 212

NLA27a.png

Kiosk 27

The Food Compass Score is negatively related to the activity of Lipoprotein-associated phospholipase A2 (Lp-PLA2) in healthy adults.

Presenting Author: Paraskevi Detopoulou, PhD
Authors: Elizabeth Fragopoulou, Tzortzis Nomikos, Smaragdi Antonopoulou

1717088456562-60e9f1da-7227-4da8-998b-6e3f5654a626_1.jpg

Poster 162

NLA27b.png

Kiosk 27

Utility of AI-QCPA: Results of the decisions for treating coronary disease are changed in patients evaluated with quantified plaque analysis

Presenting Author: Sarah Rinehart, MD
Authors: Steven J. Raible MD, Ron Blankstein MD, James Januzzi MD, Nicholas Ng, Sarah Mullen, Whitney Huey, Campbell Rogers MD, Amit Pursnani MD MSc

1717088632479-f491ca5a-9850-4d41-a13d-a0e5a0646dbc_1.jpg

Poster 191

NLA27c.png

Kiosk 27

Atrial Fibrillation Outcome in Patients with Metabolic Syndrome.

Presenting Author: Joseph Amoah, MD
Authors: Brittany Smith, Michael Fatuyi, Francisco Somaza Cano

1717089209928-da7b036c-c4f3-4e53-975b-73f5054c9f20_1.jpg

Poster 222

NLA28a.png

Kiosk 28

Optimizing residual cardiovascular risk in a case of Homozygous Familial Hypercholesterolemia (HoFH) and elevated Lipoprotein (a) [Lp(a)].

Presenting Author: Willibroad Maimo, MD
Authors: Salman Hasham PharmD, Mary Katherine Cheeley PharmD, Terry A. Jacobson MD, FNLA

1717088937846-78d051c5-5609-44d8-93dc-a60dff97544f_1.jpg

Poster 164

NLA27e.png

Kiosk 27

Study Design of a Phase 3 Randomized Controlled Trial Evaluating the Efficacy and Safety of Pegozafermin in Patients with Severe Hypertriglyceridemia

Presenting Author: Teresa Parli, MD
Authors: Deepak L. Bhatt MD MPH, Maciej Banach MD, Harold E. Bays, MD, Kevin C. Maki PhD, Kausik Ray MD, Guilliermo Umpierrez MD, Cynthia L. Hartsfield PhD, Germaine D. Agollah PhD, Hank Mansbach MD, Teresa Parli MD, John J. P. Kastelein MD PhD, Arun J. Sanyal MD.

1717089629092-527a60e1-2264-4777-a68e-4e929a3d7532_1.jpg

Poster 153

NLA28c.png

Kiosk 28

Treatment Patterns Among Early Inclisiran vs Anti–PCSK9 mAbs Users: A Retrospective Analysis of US Claims Databases

Presenting Author: Xiaoli Niu, PhD
Authors: Lyuba Popadic, Xinshuo Ma, Yousfuf Ali, Pam Kumparatana, Yuqin Wei, Sean McElligott

1717124250413-595a005a-ee95-467e-862b-d98e8341f0a4_1.jpg

Poster 158

NLA28c2.png

Kiosk 28

The IMPACT of Virtual Reality and Other Immersive Tools to Improve the Multidisciplinary Team’s Ability to Screen, Diagnose, and Manage FH

Presenting Author: Russie Allen, MS
Authors: Matthew Frese, Lauren Welch

1717090378226-4983bb66-8baa-477a-9b1c-bc64d6d39f33_1.jpg

Poster 149

NLA29a.png

Kiosk 29

Unexpected high cardiovascular risk in a healthy young patient

Presenting Author: Sohil Golwala, MD
Authors: Douglas Jacoby M.D.

1717090993231-fb3af4bb-b69b-4292-9ec4-4b5f11ea720c_1.jpg

Poster 228

NLA29c.png

Kiosk 29

Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Comple

Presenting Author: Tiffany Haynes, MD
Authors: Matthew Proute MBBS, Nosagie Ohonba MBBS, Loba Alam MD, Jeffery Feldman MD FACP, Robert Fishberg MD FACC

1717091216830-3d2e9897-0a6d-4c4a-a56c-b6c34732f176_1.jpg

Poster 196

NLA29d.png

Kiosk 29

Real-World Effectiveness and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: A Multi-site US Perspective

Presenting Author: Michael Wilkinson, MD
Authors: Priyesha Bijlani, Michael H. Davidson, P. Barton Duell, Mary Horan, Mary J. Malloy, Ron S. Newfield, Pallavi Pradeep, Prediman K. Shah, Eveline O. Stock, Bruce A. Warden, Matthew K. Ito

1717091486856-88f16073-eb4b-40c2-89ea-f38dfbd3fabe_1.jpg

Poster 143

NLA29e.png

Kiosk 29

Obicetrapib Demonstrates Significant Reductions Of Lp(a) On Top Of High-intensity Statins

Presenting Author: Sotirios Tsimikas, MD
Authors: Sotirios Tsimikas, Xiaohong Yang, Andrew Hsieh, Mary R. Dicklin, Doug Kling, Danielle Curcio, Marc Ditmarsch, Michael H. Davidson, John J.P. Kastelein

1717091954499-c845c0e1-3874-4baf-a093-c4e3df0dd294_1.jpg

Poster 128

NLA30a.png

Kiosk 30

Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis

Presenting Author: Sami Alsabri, MSc
Authors: Gadid G. Guedi, Mehdi Najar, Frédéric Lavoie, Detlev Grabs, Jean-Pierre Pelletier, Johanne Martel-Pelletier, Mohamed Benderdour, Hassan Fahmi

1717085112237-bf8e5819-c551-4ff3-a117-2dce08edf89d18-4-2024_1.jpg

Poster 107

NLA24d.png

Kiosk 30

Role and expression of 15-Prostaglandin Dehydrogenase in Cartilage tissue

Presenting Author: Sami Alsabri, MSc
Authors: Douglas Jacoby M.D.

1717092520141-a228badb-deb0-4fad-aeca-d5ffaafd852418-4-2024 (1)_1.jpg

Poster 109

NLA30c.png

Kiosk 30

Impact of familial hypercholesterolemia on Coronary Artery Dissection in patients undergoing percutaneous coronary intervention (PCI)

Presenting Author: Riaz Mahmood, DO
 

1717184564954-62a42fa1-69e3-4ddb-83e5-f62c9eeac0bd_1.jpg

Poster 235

NLA24c.png

Kiosk 24

Real-World Effectiveness and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: A Multi-site US Perspective

Presenting Author: Michael Wilkinson, MD
Authors: Priyesha Bijlani, Michael H. Davidson, P. Barton Duell, Mary Horan, Mary J. Malloy, Ron S. Newfield, Pallavi Pradeep, Prediman K. Shah, Eveline O. Stock, Bruce A. Warden, Matthew K. Ito

1717091486856-88f16073-eb4b-40c2-89ea-f38dfbd3fabe_1.jpg

Poster 143

NLA29e.png

Kiosk 29

bottom of page